According to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening its clinical offerings.

The integration of Artificial Intelligence (AI) in drug discovery is rapidly transforming the pharmaceutical industry.

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual ...

The sodium channel blocker market is expanding due to the increasing prevalence of neuropathic pain and the demand for more selective treatments like Nav1.7 and Nav1.8 inhibitors. Advances in drug ...

In a world of TikTok and other social media platforms, there seems to be a new hair growth miracle product or viral hair ...

New name reflects company's growth and vision to help bring certainty and transparency to global clinical trials ...

Researchers have created a new scale designed to capture and measure the concept of self-criticism in children, as mental ...

Belgium is scaling its regulatory and clinical systems for Advanced Therapy Medicinal Products (ATMPs) - academia's role will ...

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients with sickle cell disease (SCD), according to ...

Emerging research has uncovered disturbing links between diabetes during pregnancy and long-term neurodevelopmental outcomes ...